ConductScience.org, home

Paper2467383

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

Larder BA and 2 others. Science, 1989. Cited by 1,486 papers, by iCite.

Cite this record

ConductScience Library. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Papers, record 2467383. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2467383

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
PubMed
Journal
Science
PubMed
Year
1989
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,486
iCite
Relative citation ratio, by iCite
40.6
iCite
Revised in PubMed
2026-01-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Larder BAB A
2Darby GG
3Richman DDD D

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
HIVMajor topic
ZidovudineMajor topic
AIDS-Related Complex
Dideoxynucleosides
Drug Resistance
Foscarnet
HIV Core Protein p24
HeLa Cells
Humans
Microbial Sensitivity Tests
Phosphonoacetic Acid
Retroviridae Proteins
Reverse Transcriptase Inhibitors
Viral Plaque Assay
Virus Replication
Zalcitabine

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-52578NIAID NIH HHSUnited StatesN01AI052578PubMed and NIHNIH RePORTER
AI-62548NIAID NIH HHSUnited StatesN01AI062548PubMed and NIHNIH RePORTER
HB-67019NHLBI NIH HHSUnited StatesN01HB067019PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by389

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,486 citations.

PMIDTitleJournalYearIn PapersSource
41980093Recurrent mutations drive rapid HIV escape from two broadly neutralizing antibodies in vivo.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41980093PubMed
40573433
Consensus Sequences for Gag and Pol Introduced into HIV-1 Clade B Laboratory Strains Differentially Influence the Impact of Point Mutations Associated with Immune Escape and with Drug Resistance on Viral Replicative Capacity.
Viruses2025https://conductscience.org/library/papers/40573433PubMed
40416942Antimicrobial resistance with a focus on antibacterial, antifungal, antimalarial, and antiviral drugs resistance, its threat, global priority pathogens, prevention, and control strategies: a review.Ther Adv Infect Dis2025https://conductscience.org/library/papers/40416942PubMed
40257980Addressing data management and analysis challenges in viral genomics: The Swiss HIV cohort study viral next generation sequencing database.PLOS Digit Health2025https://conductscience.org/library/papers/40257980PubMed
39613191Efficacy assessment of antiretroviral drugs against equine infectious anemia virus in vitro.Virus Res2024https://conductscience.org/library/papers/39613191PubMed
38898037Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism.Nat Commun2024https://conductscience.org/library/papers/38898037PubMed
37940003HIV-1 Nef Changes the Proteome of T Cells Extracellular Vesicles Depleting IFITMs and Other Antiviral Factors.Mol Cell Proteomics2023https://conductscience.org/library/papers/37940003PubMed
37851634Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.PLOS Glob Public Health2023https://conductscience.org/library/papers/37851634PubMed
36992421Cellular Targets of HIV-1 Protease: Just the Tip of the Iceberg?Viruses2023https://conductscience.org/library/papers/36992421PubMed
36973419Monocyte-derived macrophages contain persistent latent HIV reservoirs.Nat Microbiol2023https://conductscience.org/library/papers/36973419PubMed
36296633Anti-HIV Ermiasolides from Croton megalocarpus.Molecules2022https://conductscience.org/library/papers/36296633PubMed
36145398Current Research on HIV Drug Resistance-A Topical Collection with "Pathogens".Pathogens2022https://conductscience.org/library/papers/36145398PubMed
36130204New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?FEMS Microbiol Rev2023https://conductscience.org/library/papers/36130204PubMed
35446679Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 science.Physiol Rev2022https://conductscience.org/library/papers/35446679PubMed
35291198AIDS at 40th: The progress of HIV treatment in Japan.Glob Health Med2022https://conductscience.org/library/papers/35291198PubMed
34578337Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics.Viruses2021https://conductscience.org/library/papers/34578337PubMed
34473060Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity.Elife2021https://conductscience.org/library/papers/34473060PubMed
33444376The clarifying role of time series data in the population genetics of HIV.PLoS Genet2021https://conductscience.org/library/papers/33444376PubMed
33364074A 35-Year Review of Pre-Clinical HIV Therapeutics Research Reported by NIH ChemDB: Influences of Target Discoveries, Drug Approvals and Research Funding.J AIDS Clin Res2020https://conductscience.org/library/papers/33364074PubMed
32362789The road to new antiviral therapies.Clin Appl Immunol Rev2005https://conductscience.org/library/papers/32362789PubMed

See all 389 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
TMED210959PubTator's text mininghttps://conductscience.org/library/genes/10959NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2467383

GET https://conductscience.org/api/papers/v1/2467383/cited_by?page=2